ropivacaine has been researched along with Invasiveness, Neoplasm in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Lian, Y; Pan, Y; Xie, K; Zhang, R; Zhu, Y | 1 |
| Chen, Y; Han, S; Hou, J; Shi, W; Zhao, L; Zhao, Y | 1 |
| Baptista-Hon, DT; Hales, TG; Lee, NH; Lydon, EL; Owen, SJ; Robertson, FM; Robertson, GB; Rogers, GW | 1 |
| Beck-Schimmer, B; Borgeat, A; Dull, RO; Minshall, RD; Piegeler, T; Schläpfer, M; Schwartz, DE | 1 |
4 other study(ies) available for ropivacaine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Hep G2 Cells; Humans; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Ropivacaine; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2021 |
The local anesthetic ropivacaine suppresses progression of breast cancer by regulating miR-27b-3p/YAP axis.
Topics: Adaptor Proteins, Signal Transducing; Anesthetics, Local; Apoptosis; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasm Invasiveness; Ropivacaine; Transcription Factors; YAP-Signaling Proteins | 2021 |
Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and NaV1.5 channel function.
Topics: Adult; Age Factors; Amides; Anesthetics, Local; Cell Movement; Collagen; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Combinations; Electrophysiological Phenomena; Humans; Infant, Newborn; Laminin; Lidocaine; NAV1.5 Voltage-Gated Sodium Channel; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Patch-Clamp Techniques; Proteoglycans; Ropivacaine | 2014 |
Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Amides; Anesthetics, Local; Caveolin 1; Cell Movement; Drug Evaluation, Preclinical; Enzyme Activation; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lidocaine; Lung Neoplasms; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Proteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Ropivacaine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2015 |